People with rheumatoid arthritis (RA) are at a higher risk for infections, including COVID-19. The risk of getting COVID is particularly high during RA flare-ups when the immune system is already ...

Oct 8 (Reuters) - Eli Lilly and Co (LLY.N), opens new tab said on Thursday fewer deaths were reported among COVID-19 patients taking a combination of its rheumatoid arthritis drug and Gilead Sciences ...

Eli Lilly said Sept. 14 that its rheumatoid arthritis drug, Olumiant, in combination with remdesivir shortened recovery time by about a day for COVID-19 patients in comparison to those treated with ...

Credit: Getty Images Based on existing literature, the potential mechanism, clinical characteristics, and treatment of COVID-19-associated arthritis is discussed. Organ pathology associated with COVID ...

Although COVID-19 vaccination significantly reduced the risk of breakthrough infection, patients with rheumatoid arthritis still had a higher risk of SARS-CoV-2 breakthrough infection. The risk of ...

Existing arthritis drugs could help stop lingering lung problems that can last up to years after COVID-19 infections, according to a study from researchers at Charlottesville, Va.-based UVA Health and ...